林艺兰,陈友兰,郭志南,等.2020年福建省厦门市恶性肿瘤流行特征及生存情况分析[J].中国肿瘤,2024,33(11):901-907.
2020年福建省厦门市恶性肿瘤流行特征及生存情况分析
Analysis of Epidemiological Characteristics and Survival of Cancers in Xiamen City of Fujian Province in 2020
投稿时间:2024-04-25  
DOI:10.11735/j.issn.1004-0242.2024.11.A004
中文关键词:  恶性肿瘤  发病  死亡  生存分析  现时法  福建
英文关键词:cancer  incidence  mortality  survival analysis  period survival analysis  Fujian
基金项目:福建省卫生健康科技计划项目(2022RKB016)
作者单位
林艺兰 厦门市疾病预防控制中心 
陈友兰 厦门市疾病预防控制中心 
郭志南 厦门市疾病预防控制中心 
池家煌 厦门市疾病预防控制中心 
摘要点击次数: 222
全文下载次数: 83
中文摘要:
      摘 要: [目的] 分析2020年福建省厦门市恶性肿瘤发病、死亡和生存情况。 [方法] 从福建省肿瘤登记信息直报平台收集2020年厦门市恶性肿瘤发病、死亡资料,计算恶性肿瘤发病和死亡的粗率、中标率、累积率、截缩率及顺位,用现时法分析5年生存率情况。[结果] 2020年厦门市户籍居民恶性肿瘤粗发病率为350.46/10万,中标率为275.12/10万,0~74岁累积率为29.70%,35~64岁截缩率为477.37/10万,发病前5位癌种为肺癌、女性乳腺癌、甲状腺癌、结直肠癌和肝癌。男性发病率高于女性(中标率:280.14/10万 vs 271.45/10万)。恶性肿瘤死亡率为150.62/10万,中标率为109.62/10万,0~74岁累积率为12.27%,35~64岁截缩率为160.38/10万,死亡前5位癌种为肺癌、肝癌、结直肠癌、食管癌和胃癌。男性死亡率高于女性(中标率:155.01/10万 vs 69.11/10万)。恶性肿瘤5年观察生存率(observed survival rate,OSR)、相对生存率(relative survival rate,RSR)和年龄标化相对生存率(age-standardized relative survival rate,ARSR)分别为53.09%(95%CI:51.80%~54.36%)、56.30%(95%CI:54.94%~57.65%)、48.14%(95%CI:46.67%~49.64%),男性5年ARSR低于女性(40.23% vs 57.75%)。[结论] 厦门市恶性肿瘤综合诊治水平处于全国中上水平,但发病率较高,应加强防控,重点关注甲状腺癌、肺癌、乳腺癌、结直肠癌等癌种的增长趋势。
英文摘要:
      Abstract:[Purpose] To analyze the incidence, mortality and survival of cancers in Xiamen City in 2020. [Methods] The data relating to the incidence and mortality of cancers in Xiamen was collected from the Tumor Registration Information Direct Reporting Platform of Fujian Province to calculate the crude rate, age-standardized rate by Chinese standard population (ASRC) , cumulative rate, truncated rate and their rank. The 5-year survival rate was analyzed by Period Analysis method. [Results] In 2020, the reported incidence rate of cancers in Xiamen residents was 350.46/105. The ASRC, the cumulative rate (0~74 years old), and the truncated rate of incidence (35~64 years old) were 275.12/105, 29.70%, 477.37/105, respectively. The top five cancers of incidence were lung cancer, female breast cancer, thyroid cancer, colorectal cancer and liver cancer. The incidence of cancers in men was higher than that in women(ASRC:280.14/105 vs 271.45/105). The curde mortality rate of cancers was 150.62/105. The ASRC, the cumulative rate (0~74 years old), and the truncated rate (35~64 years old) of mortality were 109.62/105, 12.27%, 160.38/105, respectively. The top five cancer deaths were lung cancer, liver cancer, colorectal cancer, esophagus cancer and stomach cancer. The mortality of caners in men was much higher than that in women (ASRC:155.01/105 vs 69.11/105). The 5-year observed survival rate (OSR), relative survival rate (RSR) and age-standardized relative survival rate (ARSR) were 53.09% (95%CI:51.80%~54.36%), 56.30% (95%CI:54.94%~57.65%) and 48.14% (95%CI:46.67%~49.64%), respectively. The 5-year ARSR was lower in men than that in women (40.23% vs 57.75%). [Conclusion] The comprehensive diagnosis and treatment level of cancers in Xiamen is in the middle and above level of the country, but the incidence rate is high. Prevention and control should be strengthened, focusing on the growth trend of thyroid cancer, lung cancer, breast cancer, colorectal cancer and so on.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器